EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Uncovering a Genetic Diagnosis in a Pediatric Patient by Whole Exome Sequencing: A Modeling Investigation in Wiedemann–Steiner Syndrome

Ighli di Bari, Caterina Ceccarini, Maria Curcetti, Carla Cesarano, Anna-Irma Croce, Iolanda Adipietro, Maria Grazia Gallicchio, Grazia Pia Palladino, Maria Pia Patrizio, Benedetta Frisoli, Rosa Santacroce, Maria D'Apolito iD und 4 weitere

Genes · 2024

DOI: 10.3390/genes15091155 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, 2024. Verfasst von Ighli di Bari und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy. Hauptthemen laut MEDLINE: Exome Sequencing, Myeloid-Lymphoid Leukemia Protein, Histone-Lysine N-Methyltransferase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Wiedemann–Steiner syndrome (WSS), a rare autosomal-dominant disorder caused by haploinsufficiency of the KMT2A gene product, is part of a group of disorders called chromatinopathies. Chromatinopathies are neurodevelopmental disorders caused by mutations affecting the proteins responsible for chromatin remodeling and transcriptional regulation. The resulting gene expression dysregulation mediates the onset of a series of clinical features such as developmental delay, intellectual disability, facial dysmorphism, and behavioral disorders. Aim of the Study: The aim of this study was to investigate a 10-year-old girl who presented with clinical features suggestive of WSS.

Methods

Clinical and genetic investigations were performed. Whole exome sequencing (WES) was used for genetic testing, performed using Illumina technology. The bidirectional capillary Sanger resequencing technique was used in accordance with standard methodology to validate a mutation discovered by WES in all family members who were available. Utilizing computational protein modeling for structural and functional studies as well as in silico pathogenicity prediction models, the effect of the mutation was examined.

Results

WES identified a de novo heterozygous missense variant in the KMT2A gene KMT2A(NM_001197104.2): c.3451C>G, p.(Arg1151Gly), absent in the gnomAD database. The variant was classified as Likely Pathogenetic (LP) according to the ACMG criteria and was predicted to affect the CXXC-type zinc finger domain functionality of the protein. Modeling of the resulting protein structure suggested that this variant changes the protein flexibility due to a variation in the Gibbs free energy and in the vibrational entropy energy difference between the wild-type and mutated domain, resulting in an alteration of the DNA binding affinity.

Conclusions

A novel and de novo mutation discovered by the NGS approach, enhancing the mutation spectrum in the KMT2A gene, was characterized and associated with WSS. This novel KMT2A gene variant is suggested to modify the CXXC-type zinc finger domain functionality by affecting protein flexibility and DNA binding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exome SequencingMyeloid-Lymphoid Leukemia ProteinHistone-Lysine N-MethyltransferaseHumansFemaleChildIntellectual DisabilityMutation, MissenseAbnormalities, Multiple

Stichwörter der Autor:innen

KMT2A geneWiedemann–Steiner syndromemodelingwhole exome sequencing

Substanzen

Myeloid-Lymphoid Leukemia ProteinKMT2A protein, humanHistone-Lysine N-Methyltransferase

Autor:innen und Institutionen

  • Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Neuropsychiatry for Child and Adolescent Unit, Department of Woman and Child, Policlinico Riuniti, 71122 Foggia, Italy.
  • Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

ORCID-Profile: Maria D'Apolito, Ciro Leonardo Pierri

Förderung

  • European Union

Zitieren

APA

di Bari, I., Ceccarini, C., Curcetti, M., Cesarano, C., Croce, A. I., Adipietro, I., Gallicchio, M. G., Palladino, G. P., Patrizio, M. P., Frisoli, B., Santacroce, R., D'Apolito, M., D'Andrea, G., Castriota, O. M., Pierri, C. L., & Margaglione, M. (2024). Uncovering a Genetic Diagnosis in a Pediatric Patient by Whole Exome Sequencing: A Modeling Investigation in Wiedemann–Steiner Syndrome. Genes. https://doi.org/10.3390/genes15091155

Vancouver

di Bari I, Ceccarini C, Curcetti M, Cesarano C, Croce AI, Adipietro I, et al. Uncovering a Genetic Diagnosis in a Pediatric Patient by Whole Exome Sequencing: A Modeling Investigation in Wiedemann–Steiner Syndrome. Genes. 2024. doi:10.3390/genes15091155

BibTeX
@article{diBari2024,
  author = {di Bari, Ighli and Ceccarini, Caterina and Curcetti, Maria and Cesarano, Carla and Croce, Anna-Irma and Adipietro, Iolanda and Gallicchio, Maria Grazia and Palladino, Grazia Pia and Patrizio, Maria Pia and Frisoli, Benedetta and Santacroce, Rosa and D'Apolito, Maria and D'Andrea, Giovanna and Castriota, Ombretta Michela and Pierri, Ciro Leonardo and Margaglione, Maurizio},
  title = {Uncovering a Genetic Diagnosis in a Pediatric Patient by Whole Exome Sequencing: A Modeling Investigation in Wiedemann–Steiner Syndrome},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15091155}
}
Kostenlos starten →